Rocket Lab Corporation's stock rally is justified by government contracts, global expansion, and tech growth. Click here to ...
Rocket Lab’s $816 million SDA contract boosts its status and margins. Click here to learn my analysis of RKLB stock and ...
From broad R&D to validated platforms, HPQ advances fumed silica, battery materials, and hydrogen while realigning capital ...
PhilStar Global on MSN
Filipino medical laboratory scientist recognized for contributions in the US
A Filipino expert in laboratory medicine has continued to draw recognition locally and abroad for work in Immunohematology ...
The Bengaluru-based startup received the technologies — a white grub trap and a fruit fly trap — from an NBAIR team for ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Explore This SectionEarthEarth ObserverEditor's CornerFeature ArticlesMeeting SummariesNewsScience in the NewsCalendarsIn ...
A new RapidHIT ID machine, which bears a passing resemblance to an air fryer, can generate a human DNA profile in about 90 ...
SMX's valuation story has quietly crossed a critical threshold. The company is no longer asking the market to underwrite a ...
CHENNAI: In a push to accelerate India’s deep-tech innovation pipeline, Shastra VC, an early-stage investment firm, has launched a deep-tech fellowship aimed at helping researchers convert frontier ...
TipRanks on MSN
Immunovia’s PancreaSure validation study published, bolstering early pancreatic cancer test
Immunovia AB ( ($SE:IMMNOV) ) has issued an update. Immunovia has announced that its analytical validation study of PancreaSure, a blood-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results